Matrix Capital Management Company, LP - Significant Ownership

Signature - Title
/s/ David E. Goel - David E. Goel, Managing General Partner
Location
Portsmouth, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Matrix Capital Management Company, LP.

Notify me when Matrix Capital Management Company, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Matrix Capital Management Company, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 11.17% $38.2M 6.92M Matrix Capital Management Company LP May 16, 2025
PRM Perimeter Solutions, Inc. Common stock, par value $0.0001 per share 4.48% $66.1M 6.55M Matrix Capital Management Company LP Dec 31, 2024
MAZE Maze Therapeutics, Inc. Common Stock, par value $0.001 per share 3.5% $42.9M -$21.6M 1.65M -33.5% Matrix Capital Management Company, LP Sep 30, 2025
ADAP Adaptimmune Therapeutics plc Ordinary Shares, par value 0.001 GBP per share 0% $0 -$43.2M 0 -100% Matrix Capital Management Company LP Dec 31, 2024
ALTR Altair Engineering Inc. Class A Common Stock, $0.0001 par value per share 0% $0 0 Matrix Capital Management Company, LP Mar 31, 2025

Schedules 13D/G Reported by Matrix Capital Management Company, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.